- Home
- AQST vs GCMG Comparison
AQST vs GCMG Comparison
Compare AQST & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- GCMG
- Stock Information
- Founded
- AQST 2004
- GCMG 1971
- Country
- AQST United States
- GCMG United States
- Employees
- AQST N/A
- GCMG N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- GCMG Finance/Investors Services
- Sector
- AQST Health Care
- GCMG Finance
- Exchange
- AQST Nasdaq
- GCMG Nasdaq
- Market Cap
- AQST 502.6M
- GCMG 524.4M
- IPO Year
- AQST 2018
- GCMG N/A
- Fundamental
- Price
- AQST $4.41
- GCMG $11.68
- Analyst Decision
- AQST Strong Buy
- GCMG Hold
- Analyst Count
- AQST 7
- GCMG 5
- Target Price
- AQST $9.43
- GCMG $12.80
- AVG Volume (30 Days)
- AQST 1.7M
- GCMG 244.5K
- Earning Date
- AQST 11-04-2024
- GCMG 11-08-2024
- Dividend Yield
- AQST N/A
- GCMG 3.77%
- EPS Growth
- AQST N/A
- GCMG N/A
- EPS
- AQST N/A
- GCMG N/A
- Revenue
- AQST $58,900,000.00
- GCMG $462,593,000.00
- Revenue This Year
- AQST $18.45
- GCMG $15.24
- Revenue Next Year
- AQST N/A
- GCMG $13.65
- P/E Ratio
- AQST N/A
- GCMG $154.07
- Revenue Growth
- AQST 22.56
- GCMG 8.20
- 52 Week Low
- AQST $1.69
- GCMG $8.04
- 52 Week High
- AQST $6.23
- GCMG $12.43
- Technical
- Relative Strength Index (RSI)
- AQST 37.69
- GCMG 51.57
- Support Level
- AQST $4.62
- GCMG $10.91
- Resistance Level
- AQST $5.59
- GCMG $12.43
- Average True Range (ATR)
- AQST 0.37
- GCMG 0.33
- MACD
- AQST -0.11
- GCMG -0.03
- Stochastic Oscillator
- AQST 2.54
- GCMG 50.66
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.